Urology News and Research

Latest Urology News and Research

USC, CHLA receive prestigious Clinical and Translational Science Award from NIH

On June 30, 2016, a team of researchers led by Thomas Buchanan, MD, Michele Kipke PhD and Jonathan Samet, MD, of the Keck School of Medicine of the University of Southern California received a prestigious Clinical and Translational Science Award (CTSA) from the National Institutes of Health.

10 Jul 2016

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at Case Western Reserve University and Johns Hopkins Medical Institutions shows.

6 Jul 2016

Early detection, treatment key to testicular cancer cure

When women feel a lump in their breast, they usually seek medical attention within a few weeks. Yet men who notice something abnormal in a testicle typically don't see a doctor for two to three months.

30 Jun 2016

High levels of zinc may lead to kidney stone formation

David Killilea, PhD, a staff scientist at Children's Hospital Oakland Research Institute- the research arm of UCSF Benioff Children's Hospital Oakland - co-authored a study into the causes of kidney stones.

28 Jun 2016

Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

Slightly more than 10% of all patients who undergo successful surgery for prostate cancer have an elevated risk of tumor recurrence afterwards - especially as metastases.

27 Jun 2016

NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

Leading NYU Lutheran's fight is Marc Bjurlin, DO, the hospital's newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine.

27 Jun 2016

Experts develop set of resolutions, conclusions to provide clarity on testosterone therapy

In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide clarity for physicians and patients.

21 Jun 2016

Cabozantinib extends advanced RCC overall survival

Patients with advanced or metastatic renal cell carcinoma derive a significant overall survival benefit from second-line treatment with the multi-tyrosine kinase inhibitor cabozantinib relative to everolimus.

18 Jun 2016

ERCC2 validated as chemotherapy response biomarker in bladder cancer

Somatic mutations in the helicase-encoding ERCC2 gene are associated with response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive urothelial bladder carcinoma.

17 Jun 2016

Black children more likely to have postsurgical complications after urologic surgery

Black children who undergo urologic surgery are more likely than white children to have postsurgical complications and hospital-acquired infections 30 days after the surgery.

17 Jun 2016

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

16 Jun 2016

New analytical technology could improve cancer treatment by establishing ideal dosing regimens

University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate

15 Jun 2016

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk.

14 Jun 2016

MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation - the precise application of heat via laser to a tumor - is both feasible and safe in men with intermediate risk prostate cancer.

10 Jun 2016

UAB receives new image-guided robotic system for early prostate cancer diagnosis

The world-renowned iSR'obotTM Mona Lisa makes its way to the United States, providing urologic surgeons with a tool to diagnose prostate cancer earlier through accurate diagnosis and precise localization that may allow for targeted treatments in the future.

9 Jun 2016

Robotic-assisted radical prostatectomy may reduce risk of blood loss, prolonged hospital stays in obese men

In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found.

23 May 2016

Researchers urge specific guidelines for fertility, sexual function counseling in at-risk pediatric patients

The drugs and therapies used to treat medical conditions often come with side effects. Doctors, pharmacists and other health care professionals strive to be sure we are made aware.

20 May 2016

Innovative research technique may help understand early stage kidney disease

UT Dallas scientists are developing an innovative research technique that could help urologists better understand the early stages of kidney disease.

19 May 2016

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research presented today at the American Urological Association annual meeting.

12 May 2016

Combination of hormone therapy and radiotherapy halves risk of death from prostate cancer

A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of death from prostate cancer 15 years after diagnosis. This according to a follow-up study recently published in the journal European Urology.

10 May 2016

Urology News and Research

Latest Urology News and Research

USC, CHLA receive prestigious Clinical and Translational Science Award from NIH

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Early detection, treatment key to testicular cancer cure

High levels of zinc may lead to kidney stone formation

Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

Experts develop set of resolutions, conclusions to provide clarity on testosterone therapy

Cabozantinib extends advanced RCC overall survival

ERCC2 validated as chemotherapy response biomarker in bladder cancer

Black children more likely to have postsurgical complications after urologic surgery

Drinking piping hot beverages may increase risk of esophagus tumors

New analytical technology could improve cancer treatment by establishing ideal dosing regimens

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

UAB receives new image-guided robotic system for early prostate cancer diagnosis

Robotic-assisted radical prostatectomy may reduce risk of blood loss, prolonged hospital stays in obese men

Researchers urge specific guidelines for fertility, sexual function counseling in at-risk pediatric patients

Innovative research technique may help understand early stage kidney disease

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

Combination of hormone therapy and radiotherapy halves risk of death from prostate cancer

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in